Volume 1 Issue 1 of Drug Discovery and Development (June-September) has launched.
Dedicated to the needs of biotech and pharma leaders, this journal of pharma intelligence serves to advance drug discovery into active medical solutions.
This journal aims to help readers accelerate clinical milestones into commercial success.
This edition explores:
• Thought-leading approaches to cell and gene therapies
• Advances in anti-drug conjugates
• Neurology and degenerative diseases
• AI in drug discovery and development
• And much more.
Part of Pharma Press Global Intelligence, based in London, UK, Drug Discovery and Development’s targeted audience is spilt between Europe and North America.
Drug Discovery and Development is a subscription-only journal, published three times a year.
Please email subs@pharmapress.co.uk to purchase a print subscription to this publication.
